Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
UBE2CP4 is a **pseudogene** located in the human genome, classified as a non-functional gene remnant related to the UBE2C family (ubiquitin conjugating enzymes)[1]. Unlike canonical UBE2C, which encodes an enzyme involved in the ubiquitination pathway—a critical process for protein degradation and cell cycle regulation—UBE2CP4 does not produce a functional protein and has no assigned molecular or therapeutic function[1][2]. Pseudogenes such as UBE2CP4 may influence cellular function via regulatory non-coding RNA actions in rare cases, but there_is currently no published evidence supporting a biological or clinical role for UBE2CP4 specifically[5]. It is not considered a molecular target, receptor, enzyme, transporter, or therapeutic target for drug development. UBE2CP4 is a pseudogene, not a valid molecular target for drug development or therapy. There is no additional information beyond its genomic annotation[1].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ubiquitin conjugating enzyme E2 C pseudogene 4 (UBE2CP4).